About: Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
Author	Yakoub-Agha, Ibrahim (1962-....) Moreau, Philippe (1969-.... ; professeur en chimie des matériaux) Blancho, Gilles Mohty, Mohamad (19..-.... ; hématologue) Malard, Florent (1982-....) Blaise, Didier (1955-....) Chevallier, Patrice (1970-) Vanhove, Bernard Gaugler, Béatrice (19..-....) Guillaume, Thierry
Bibliographic Citation	Malard Florent, Labopin Myriam, Yakoub-Agha Ibrahim, Chantepie Sylvain, Guillaume Thierry, Blaise Didier, Tabrizi Reza, Magro Leonardo, Vanhove Bernard, Blancho Gilles, Moreau Philippe, Gaugler Béatrice, Chevallier Patrice, Mohty Mohamad. Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study. Blood, American Society of Hematology, 2017, 130 (20), pp.2186-2195. ⟨10.1182/blood-2017-05-786137⟩ Malard Florent, Vanhove Bernard, Blancho Gilles. Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study. Blood, 2017, 130 (20), pp.2186-2195. ⟨10.1182/blood-2017-05-786137⟩
Title	Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study
dc:date	2017
Digital Object Identifier (DOI)	10.1182/blood-2017-05-786137

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software